Clinical Trial Update: Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study

View source ↗

Summary

A completed Danish population-based follow-up study assessing outcomes in children aged 5-10 years after extreme neonatal hyperbilirubinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hyperbilirubinemia

Snippet

Sponsor: University of Aarhus | Conditions: Neonatal Hyperbilirubinemia | Status: COMPLETED